Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

MANCUSO, Salvatrice
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.953
EU - Europa 4.394
AS - Asia 4.224
SA - Sud America 690
Continente sconosciuto - Info sul continente non disponibili 562
AF - Africa 104
OC - Oceania 9
Totale 20.936
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.741
SG - Singapore 1.560
RU - Federazione Russa 1.211
CN - Cina 1.032
IT - Italia 1.028
BR - Brasile 509
DE - Germania 449
HK - Hong Kong 421
FI - Finlandia 361
VN - Vietnam 352
PL - Polonia 258
UA - Ucraina 227
GB - Regno Unito 193
JP - Giappone 178
FR - Francia 176
BD - Bangladesh 151
IE - Irlanda 130
SE - Svezia 115
IN - India 114
CA - Canada 98
KR - Corea 81
NL - Olanda 57
AR - Argentina 48
IQ - Iraq 47
TR - Turchia 44
MX - Messico 43
CO - Colombia 38
RO - Romania 33
ES - Italia 32
PK - Pakistan 29
VE - Venezuela 29
AT - Austria 28
ID - Indonesia 28
IR - Iran 27
ZA - Sudafrica 24
BE - Belgio 23
CR - Costa Rica 22
EC - Ecuador 22
UZ - Uzbekistan 22
SA - Arabia Saudita 20
JM - Giamaica 17
UY - Uruguay 16
CH - Svizzera 15
MA - Marocco 14
MY - Malesia 14
CI - Costa d'Avorio 13
CL - Cile 13
JO - Giordania 13
PH - Filippine 13
EG - Egitto 12
NP - Nepal 12
CZ - Repubblica Ceca 11
KE - Kenya 11
IL - Israele 9
PY - Paraguay 9
AU - Australia 8
BG - Bulgaria 8
DZ - Algeria 7
EU - Europa 7
GR - Grecia 7
LT - Lituania 7
KZ - Kazakistan 6
TN - Tunisia 6
AE - Emirati Arabi Uniti 5
AL - Albania 5
LB - Libano 5
OM - Oman 5
PT - Portogallo 5
AZ - Azerbaigian 4
BB - Barbados 4
BH - Bahrain 4
BO - Bolivia 4
DO - Repubblica Dominicana 4
ET - Etiopia 4
HN - Honduras 4
KG - Kirghizistan 4
NI - Nicaragua 4
SV - El Salvador 4
TH - Thailandia 4
AO - Angola 3
DK - Danimarca 3
EE - Estonia 3
GH - Ghana 3
GT - Guatemala 3
HR - Croazia 3
KW - Kuwait 3
SI - Slovenia 3
SY - Repubblica araba siriana 3
CY - Cipro 2
MM - Myanmar 2
PA - Panama 2
PR - Porto Rico 2
SR - Suriname 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
BF - Burkina Faso 1
BN - Brunei Darussalam 1
BW - Botswana 1
CG - Congo 1
CW - ???statistics.table.value.countryCode.CW??? 1
Totale 20.364
Salva come PNG Salva come JPEG
Città #
Ashburn 1.248
Fairfield 1.076
Singapore 981
San Jose 763
Chandler 532
Woodbridge 500
Houston 497
Wilmington 441
Hong Kong 406
Seattle 389
Cambridge 364
Secaucus 339
Ann Arbor 269
Council Bluffs 265
Zgierz 228
Beijing 211
Moscow 194
Palermo 165
Los Angeles 163
Medford 160
Tokyo 157
Des Moines 153
Dallas 149
Helsinki 146
Santa Clara 136
New York 134
Dublin 129
Ho Chi Minh City 110
Nanjing 106
Lauterbourg 104
Altamura 103
Princeton 103
Frankfurt am Main 102
Jacksonville 100
Hanoi 89
Chicago 86
Dearborn 82
The Dalles 82
Hefei 81
Boardman 80
Buffalo 78
Lawrence 75
Rome 74
Milan 67
San Diego 66
São Paulo 46
Tulsa 44
Columbus 39
Ludwigshafen am Rhein 39
Atlanta 37
Shenyang 36
Phoenix 33
London 32
Orem 32
Amsterdam 31
Toronto 30
Brooklyn 28
Hebei 28
Nanchang 27
Seoul 27
Tianjin 27
Denver 24
Brussels 23
Changsha 22
Jinan 22
Ningbo 22
Chennai 21
Jiaxing 21
Guangzhou 20
San José 20
Tashkent 19
Nuremberg 18
Piscataway 18
Poplar 18
Warsaw 18
Zhengzhou 18
Baghdad 17
Rio de Janeiro 17
Venice 17
Washington 17
Da Nang 16
Montreal 16
Bremen 15
San Paolo di Civitate 15
Tehran 15
Curitiba 14
Kumar 14
Lappeenranta 14
Redwood City 14
San Francisco 14
Shanghai 14
Abidjan 13
Hangzhou 13
Mumbai 13
Naples 13
Stockholm 13
Haiphong 12
Montevideo 12
Saint Petersburg 12
Amman 11
Totale 12.964
Salva come PNG Salva come JPEG
Nome #
Absolute Lymphocyte Count Is Unrelated to Overall Survival in Newly Diagnosed Elderly Patients with Multiple Myeloma Treated with Immunomodulatory Drugs. 509
Copanlisib in combination with rituximab and bendamustine for transplant-ineligible relapsed/refractory diffuse large B-cell lymphoma patients: Results from the phase II multicentre FIL Copa-BR trial from Fondazione Italiana Linfomi (FIL) 455
The Essential Thrombocythemia in 2020: What We Know and Where We Still Have to Dig Deep 434
Clinical phenotype and response to different lines of therapy in elderly with immune thrombocytopenia: A retrospective study 340
Comparison between thrombotic risk scores in Essential Thrombocythemia and survival implications 314
Cardiovascular risk in polycythemia vera: Thrombotic risk and survival: Can cytoreductive therapy be useful in patients with low-risk polycythemia vera with cardiovascular risk factors? 291
Efficacy of ruxolitinib retreatment in a patient with high-risk myelofibrosis using the international prognostic scoring system 287
Optimal Duration of Low Molecular Weight Heparin for the Treatment of Cancer-Related Deep Vein Thrombosis: The Cancer-DACUS Study. 284
Buffy coat-derived platelets cryopreserved using a new method: Results from a pivotal clinical trial on thrombocytopenic patients with acute leukaemia 270
Acquired haemophilia in cancer: A systematic and critical literature review 267
Combined Point of Care Tools Are Able to Improve Treatment Adherence and Health-Related Quality of Life in Patients with Severe Hemophilia: An Observational Prospective Study 246
T Cell Large Granular Lymphocytic Leukemia in Association with Sjógren's Syndrome 240
Evaluation of the prognostic role of tumour-associated macrophages in newly diagnosed classical hodgkin lymphoma and correlation with early FDG-PET assessment 240
Acquired Hemophilia A Associated with Venous Thrombosis and Very High Inhibitor Titer: A Challenging Scenario 239
Antimicorbial prophylaxis in patients with immune thrombocytopenia treated with rituximab:a retrospective analysis 227
Buffy coat-derived platelets cryopreserved using a new method: Results from in vitro studies 226
A Case of Fatal Drug Rash Eosinophilia and Systemic Symptoms from Allopurinol 223
CARDIOVASCULAR RISK IN ESSENTIAL THROMBOCYTHEMIA AND POLYCYTHEMIA VERA: THROMBOTIC RISK AND SURVIVAL 223
Immunosenescence and lymphomagenesis 221
Screening sierologico per l'infantum in soggetti HIV+ in area endemica Sicilia occidentale 219
Efficacy of bendamustine and rituximab in splenic marginal zone lymphoma: results from the phase II BRISMA/IELSG36 study 219
Synthesis and induction of G0-G1 phase arrest with apoptosis of 3,5-dimethyl-6-phenyl-8-(trifluoromethyl)-5,6-dihydropyrazolo[3,4-f][1,2,3,5]tetrazepin-4(3H)-one 218
Late onset of unilateral optic disk edema secondary to treatment with imatinib mesylate 217
Cardio-oncology in multiple myeloma: is it time for a specific focus? 216
Antiviral treatment in patients with indolent B-cell lymphomas associated with HCV infection: a study of the Fondazione Italiana Linfomi 215
COMPARISON OF CLINICAL AND LABORATORY DATA, INCLUDING JAK-2 46/1 HAPLOTYPE, BETWEEN PATIENTS WITH IDIOPATHIC ERYTHROCYTOSIS AND POLYCYTHEMIA VERA. 214
Screening sierologico per Leishmania infantum su donatori di sangue e HIV+ asintomatici residenti in area endemica [Serological screening for Leishmania infantum in asymptomatic blood donors and HIV+ patients living in an endemic area] 213
Bendamustine with or without rituximab in the treatment of relapsed chronic lymphocytic leukaemia: an Italian retrospective study. 210
DETECTION OF HIV TYPE 1 (HIV-1) NON-B SUBTYPES IN SICILY, ITALY 208
Comprehensive Geriatric Assessment is an essential tool to support treatment decisions in elderly patients with Diffuse Large B Cell Lymphoma: A prospective multicenter evaluation on 173 patients by the Lymphoma Italian Foundation (FIL) 207
Rituximab with cyclophosphamide, vincristine, non-pegylated liposomal doxorubicin and prednisone as first-line treatment for splenic marginal zone lymphoma: A Fondazione Italiana Linfomi phase II study 207
Evaluation of Bone Marrow CD8+ tissue-Resident Memory T Cells in Multiple Myeloma 204
PNEUMOCYSTIS JIROVECI PNEUMONIA IN HEMATOLOGICAL PATIENTS: A SINGLE INSTITUTION EXPERIENCE 203
JAK2 ALLELE BURDEN IN PATIENTS WITH PHILADELPHIA NEGATIVE MYELOPROLIFERATIVE NEOPLASMS 198
Clinical history of thrombosis before diagnosis of overt myeloproliferative neoplasms in triple negative patients 197
Genetic diversity of HIV-1 non-B strains in Sicily: Evidence of intersubtype recombinants by Sequence Analysis of gag, pol, and env genes 193
A novel methodology for large-scale phylogeny partition 193
Cardiovascular risk factor in MPN patients 193
BENDAMUSTINE (B) IN COMBINATION WITH RITUXIMAB (R) FOR PATIENTS WITH RELAPSED/RESISTANT CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): AN ITALIAN MULTICENTRE RETROSPECTIVE STUDY 192
Coexistence of Von Willebrand disease and gastrointestinal stromal tumor (G.I.S.T): Case report of a rare and challenge association 187
ABSOLUTE LYMPHOCYTE COUNT IS NOT A PREDICTOR FOR SURVIVAL IN NEWLY DIAGNOSED ELDERLY PATIENTS WITH MULTIPLE MYELOMA. FINAL RESULTS OF A MULTICENTER STUDY 186
The Essential Thrombocythemia, Thrombotic Risk Stratification, and Cardiovascular Risk Factors 185
A prognostic model for estimating the time to virologic failure in HIV-1 infected patients undergoing a new combination antiretroviral therapy regimen 179
Antiretroviral genotypic resistance in plasma RNA and whole blood DNA in HIV-1 infected patients failing HAART 178
"Long term anticoagulant treatment management in patients with portal vein thrombosis at high bleeding risk" 178
Lymphomas and thyroid: Bridging the gap 178
ABSOLUTE LYMPHOCYTE COUNT AS PREDICTOR FOR SURVIVAL IN NEWLY DIAGNOSED ELDERLY PATIENTS WITH MULTIPLE MYELOMA 176
Isolated Nodal TBC Reactivation in a Patient with Post-Thrombocythemia Myelofibrosis Treated with Ruxolitinib: Case Report and Review of the Literature 174
BENDAMUSTINE IN ASSOCIATION WITH RITUXIMAB AS SALVAGE THERAPY FOR SPLENIC MARGINAL ZONE LYMPHOMA 172
MESENCHYMAL STEM CELLS IN PH-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS: IDLE OBSERVERS OR PART OF THE DISEASE? 172
Management of Ponatinib in Patients with Chronic Myeloid Leukemia with Cardiovascular Risk Factors 172
Thrombotic complications in paroxysmal nocturnal haemoglobinuria: a literature review. 171
EBF1, MYO6 and CALR expression levels predict therapeutic response in diffuse large B-cell lymphomas 167
ABSOLUTE LYMPHOCYTE COUNT IS NOT A PREDICTOR FOR SURVIVAL IN NEWLY DIAGNOSED ELDERLY PATIENTS WITH MULTIPLE MYELOMA 167
Synthesis and induction of G0-G1 phase arrest with apoptosis of 3,5-dimethyl-6-phenyl-8-trifluoromethyl-5,6-dihydropyrazolo[3,4-f][1,2,3,5]tetrazepin-4-one 166
CD200 ANTIGEN IN B-CELL DERIVED NEOPLASMS: EXPRESSION AND CLINICAL IMPACT IN 77 CONSECUTIVE PATIENTS OF A SINGLE ISTITUTION 166
The difference of free light chains as a predictor of kidney damage in patients with Multiple Myeloma 164
Chronic myeloid leukemia as second malignancy; a retrospective multicentrico study 162
CANCER AS A PREDICTOR FOR INCREASED PERIPROCEDURAL BLEEDING DURING SURGERY OR PLATELET-INDUCED CHEMOTHERAPY IN CHRONICALLY ANTICOAGULATED PATIENTS 162
INFEZIONE DA HIV E IMMIGRATI NEGLI ULTIMI CINQUE ANNI DI ATTIVITA' DEL NOSTRO CENTRO 160
Single-dose palonosetron for prevention of chemotherapy-induced nausea and vomiting in patients with aggressive non-Hodgkin's lymphoma receiving moderately emetogenic chemotherapy containing steroids: results of a phase II study from the Gruppo Italiano per lo Studio dei Linfomi (GISL). 159
Host-related factors and cancer: Malnutrition and non-Hodgkin lymphoma 159
Changes over time in risk factors for cardiovascular disease and use of lipid-lowering drugs in HIV-infected individuals and impact on myocardial infarction 158
Molecular-Biology-Driven Frontline Treatment for Chronic Lymphocytic Leukemia: A Network Meta-Analysis of Randomized Clinical Trials 155
Thrombotic risk in paroxysmal nocturnal hemoglobinuria-like (PNH-like) phenotype 155
Evolution of transmitted HIV-1 drug resistance in HIV-1-infected patients in Italy from 2000 to 2010 155
“Evidence of HIV-1 second-generation recombinant strains (SGRs) in Sicily: sequence analysis of gag, pol, and env genes.” 154
Lymphonodal amyloidosis: case report 154
Rules-based HIV-1 genotypic resistance interpretation systems predict 8 week and 24 week virological antiretroviral treatment outcome and benefit from drug potency weighting 154
Cardiovascular Issues in Tyrosine Kinase Inhibitors Treatments for Chronic Myeloid Leukemia: A Review 153
Cardiovascular toxicity induced by TKIs in patients with chronic myeloid leukaemia: Are women and men different? 151
MOLECULAR EPIDEMIOLOGY OF HIV TYPE 1 (HIV-1) NON-B SUBTYPES IN SICILY 150
Genotypic resistance profiles associated with virological failure to darunavir-containing regimens: A cross-sectional analysis 150
PREDICTORS OF RESIDUAL VEIN THROMBOSIS AFTER CANCER-RELATED DEEP VEIN THROMBOSIS OF THE LOWER LIMBS 148
Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration 148
Functional In Vitro Studies Of Buffy Coat Pooled Platelets Cryopreserved In Dimethyl-Sulphoxide With a New System 145
Recent acquired STD and the use of HAART in the Italian Cohort of Naive for Antiretrovirals (I.Co.N.A): Analysis of the incidence of newly acquired hepatitis B infection and syphilis 145
Bone damage after chemotherapy for lymphoma: a real-world experience 145
Paroxysmal nocturnal haemoglobinuria: When delay in diagnosis and long therapy occurs 143
E' la pneumocistosi ancora presente in pazienti HIV positivi in epoca HAART? 142
Low rate of virological failure and maintenance of susceptibility to HIV-1 protease inhibitors with first-line lopinavir/ritonavir-based antiretroviral treatment in clinical practice 142
Dimagrimento e diarrea: oltre la "wasting syndrome" 141
Duration of first-line antiretroviral therapy with tenofovir and emtricitabine combined with atazanavir/ritonavir, efavirenz or lopinavir/ritonavir in the Italian ARCA cohort 141
Long-term CD4+ T-cell count evolution after switching from regimens including HIV nucleoside reverse transcriptase inhibitors (NRTI) plus protease inhibitors to regimens containing NRTI plus non-NRTI or only NRTI 141
Prevalence of acquired resistance mutations in a large cohort of perinatally infected HIV-1 patients 140
Paroxysmal nocturnal hemoglobinuria-like phenotype and thrombotic risk in several clinical disorders 137
Detection of drug resistance mutations at low plasma HIV-1 RNA load in a European multicentre cohort study 137
AIDS AND SURGICAL PATIENTS 136
Bendamustin in association with Rituximab (BR) in the treatment of patients with relapsed/refractory lymphoid neoplasm. A GISL retrospective study 135
Declining prevalence of HIV-1 drug resistance in antiretroviral treatment-exposed individuals in Western Europe 134
Effects of B-Cell Lymphoma on the Immune System and Immune Recovery after Treatment: The Paradigm of Targeted Therapy 134
Familial essential thrombocythemia: 6 cases from a mono‐institutional series 134
Nutritional factors and survival in a cohort of patients with myelofibrosis 133
Chronic myeloid leukemia as second malignancy; restrospective multicentric study 132
High Output Heart Failure in Multiple Myeloma: Pathogenetic Considerations 129
Molecular epidemiology of HIV type 1 (HIV-1) non-B subtypes in SIcily 128
No pol mutation is associated independently with the lack of immune recovery in patients infected with HIV and failing antiretroviral therapy 128
Triple-Negativity Identifies a Subgroup of Patients with Better Overall Survival in Essential Thrombocythemia 128
Variable impact on mortality of AIDS-defining events diagnosed during combination antiretroviral therapy: Not All AIDS-defining conditions are created equal 127
Prevalence of Giardia, Cryptosporidium and Isospora in HIv-seropositive individuals in Sicily. 124
Totale 18.998
Salva come PNG Salva come JPEG
Categoria #
all - tutte 69.504
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 69.504
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022852 0 0 0 49 19 57 63 68 139 187 73 197
2022/20231.597 155 299 29 164 172 259 107 127 183 27 48 27
2023/2024737 29 103 61 103 55 139 76 24 6 19 18 104
2024/20251.916 57 96 74 177 92 58 132 149 154 208 268 451
2025/20267.877 552 655 372 534 735 1.045 1.094 756 630 859 297 348
2026/20271.770 402 426 883 59 0 0 0 0 0 0 0 0
Totale 20.936